247 related articles for article (PubMed ID: 37480270)
1. Role of Nanocarrier Systems in Drug Delivery for Overcoming Multi-Drug Resistance in Bacteria.
Qumsani AT
Pak J Biol Sci; 2023 Feb; 26(3):131-137. PubMed ID: 37480270
[TBL] [Abstract][Full Text] [Related]
2. Overcoming Multidrug Resistance in Bacteria Through Antibiotics Delivery in Surface-Engineered Nano-Cargos: Recent Developments for Future Nano-Antibiotics.
Yang X; Ye W; Qi Y; Ying Y; Xia Z
Front Bioeng Biotechnol; 2021; 9():696514. PubMed ID: 34307323
[TBL] [Abstract][Full Text] [Related]
3. Nano-therapeutics: A revolution in infection control in post antibiotic era.
Zaidi S; Misba L; Khan AU
Nanomedicine; 2017 Oct; 13(7):2281-2301. PubMed ID: 28673854
[TBL] [Abstract][Full Text] [Related]
4. Thymol-Decorated Gold Nanoparticles for Curing Clinical Infections Caused by Bacteria Resistant to Last-Resort Antibiotics.
Huang Z; Zhang X; Yao Z; Han Y; Ye J; Zhang Y; Chen L; Shen M; Zhou T
mSphere; 2023 Jun; 8(3):e0054922. PubMed ID: 37017551
[TBL] [Abstract][Full Text] [Related]
5. Bacterial genome engineering and synthetic biology: combating pathogens.
Krishnamurthy M; Moore RT; Rajamani S; Panchal RG
BMC Microbiol; 2016 Nov; 16(1):258. PubMed ID: 27814687
[TBL] [Abstract][Full Text] [Related]
6. From Nano to Micro: using nanotechnology to combat microorganisms and their multidrug resistance.
Natan M; Banin E
FEMS Microbiol Rev; 2017 May; 41(3):302-322. PubMed ID: 28419240
[TBL] [Abstract][Full Text] [Related]
7. Antibiotic resistance in microbes: History, mechanisms, therapeutic strategies and future prospects.
Uddin TM; Chakraborty AJ; Khusro A; Zidan BRM; Mitra S; Emran TB; Dhama K; Ripon MKH; Gajdács M; Sahibzada MUK; Hossain MJ; Koirala N
J Infect Public Health; 2021 Dec; 14(12):1750-1766. PubMed ID: 34756812
[TBL] [Abstract][Full Text] [Related]
8. Nanoparticles as antibiotic-delivery vehicles (ADVs) overcome resistance by MRSA and other MDR bacterial pathogens: The grenade hypothesis.
Alabresm A; Chen YP; Wichter-Chandler S; Lead J; Benicewicz BC; Decho AW
J Glob Antimicrob Resist; 2020 Sep; 22():811-817. PubMed ID: 32653724
[TBL] [Abstract][Full Text] [Related]
9. A mechanistic perspective on targeting bacterial drug resistance with nanoparticles.
Khorsandi K; Keyvani-Ghamsari S; Khatibi Shahidi F; Hosseinzadeh R; Kanwal S
J Drug Target; 2021 Nov; 29(9):941-959. PubMed ID: 33703979
[TBL] [Abstract][Full Text] [Related]
10. The Potential of Antibiotics and Nanomaterial Combinations as Therapeutic Strategies in the Management of Multidrug-Resistant Infections: A Review.
Adeniji OO; Nontongana N; Okoh JC; Okoh AI
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499363
[TBL] [Abstract][Full Text] [Related]
11. Coping with antibiotic resistance: combining nanoparticles with antibiotics and other antimicrobial agents.
Allahverdiyev AM; Kon KV; Abamor ES; Bagirova M; Rafailovich M
Expert Rev Anti Infect Ther; 2011 Nov; 9(11):1035-52. PubMed ID: 22029522
[TBL] [Abstract][Full Text] [Related]
12. Antibiotic adjuvants: synergistic tool to combat multi-drug resistant pathogens.
Kumar V; Yasmeen N; Pandey A; Ahmad Chaudhary A; Alawam AS; Ahmad Rudayni H; Islam A; Lakhawat SS; Sharma PK; Shahid M
Front Cell Infect Microbiol; 2023; 13():1293633. PubMed ID: 38179424
[TBL] [Abstract][Full Text] [Related]
13. Nanotechnology as a therapeutic tool to combat microbial resistance.
Pelgrift RY; Friedman AJ
Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1803-15. PubMed ID: 23892192
[TBL] [Abstract][Full Text] [Related]
14. Engineering hybrid nanosystems for efficient and targeted delivery against bacterial infections.
Elhassan E; Devnarain N; Mohammed M; Govender T; Omolo CA
J Control Release; 2022 Nov; 351():598-622. PubMed ID: 36183972
[TBL] [Abstract][Full Text] [Related]
15. Endocytosis-mediated redistribution of antibiotics targets intracellular bacteria.
Qu S; Zhu K
Nanoscale; 2023 Mar; 15(10):4781-4794. PubMed ID: 36779877
[TBL] [Abstract][Full Text] [Related]
16. Breakthroughs in bacterial resistance mechanisms and the potential ways to combat them.
Khameneh B; Diab R; Ghazvini K; Fazly Bazzaz BS
Microb Pathog; 2016 Jun; 95():32-42. PubMed ID: 26911646
[TBL] [Abstract][Full Text] [Related]
17. Pulling the Brakes on Fast and Furious Multiple Drug-Resistant (MDR) Bacteria.
Khan AA; Manzoor KN; Sultan A; Saeed M; Rafique M; Noushad S; Talib A; Rentschler S; Deigner HP
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33467089
[TBL] [Abstract][Full Text] [Related]
18. Recent advances in antibacterial applications of metal nanoparticles (MNPs) and metal nanocomposites (MNCs) against multidrug-resistant (MDR) bacteria.
Alavi M; Rai M
Expert Rev Anti Infect Ther; 2019 Jun; 17(6):419-428. PubMed ID: 31046483
[No Abstract] [Full Text] [Related]
19. Nanotargeting of Resistant Infections with a Special Emphasis on the Biofilm Landscape.
Alabresm A; Chandler SL; Benicewicz BC; Decho AW
Bioconjug Chem; 2021 Aug; 32(8):1411-1430. PubMed ID: 34319073
[TBL] [Abstract][Full Text] [Related]
20. Antibiotic resistance: The challenges and some emerging strategies for tackling a global menace.
Chinemerem Nwobodo D; Ugwu MC; Oliseloke Anie C; Al-Ouqaili MTS; Chinedu Ikem J; Victor Chigozie U; Saki M
J Clin Lab Anal; 2022 Sep; 36(9):e24655. PubMed ID: 35949048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
